RNAM2019-04-012019-06-30in-bse-fin:OneOperatingExpenses01Member RNAM2019-04-012019-06-30in-bse-fin:OneOperatingExpenses02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares RNAM 2019-04-01 2020-03-31 2019-07-22 INR Crores First quarter Single segment The Company is in the business of providing asset management services to the fund and portfolio management service to clients. The primary segment is identified as asset management services. As such the Company’s financial statements is largely reflective of the asset management business and there is no separate reportable segment. 2019-04-01 2019-06-30 Unaudited Consolidated 3251100000.00 353000000.00 3604100000.00 0.00 0.00 0.00 825000000.00 17200000.00 76200000.00 880300000.00 1798700000.00 1805400000.00 0.00 1805400000.00 590100000.00 -40700000.00 549400000.00 0.00 1256000000.00 0.00 0.00 0.00 -2000000.00 1254000000.00 -14400000.00 1239600000.00 1254000000.00 0.00 1239600000.00 0.00 6120000000.00 10 2.05 2.05 0.00 0.00 2.05 2.05 0.00 0.00 0.00 1.tThe financial results have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 - Interim Financial Reporting, notified under Section 133 of the Companies Act, 2013 read with Companies (Indian Accounting Standards) Rules, 2015, as amended from time to time, and other accounting principles generally accepted in India.ttttt n2.tEffective April 1, 2019, Company has adopted Ind AS 116 Leases , applied to all lease contracts existing on April 1, 2019 using the modified retrospective method and has taken the cumulative adjustment to retained earnings, on the date of initial application. Accordingly, comparatives for the year ended March 31, 2019 have not been retrospectively adjusted. On transition, the adoption of the new standard resulted in recognition of Right-of-Use asset of Rs 79.36 crore and a lease liability of Rs 86.01 crore. The cumulative effect of applying the standard resulted in Rs 4.32 crore being debited to retained earnings, net of taxes. The effect of this adoption is insignificant on the profit for the period and earnings per share.ttttt n3.tAs at June 30, 2019, the Company has outstanding Inter Corporate Deposits (ICDs) exposure to group companies, other than subsidiaries, amounting to Rs 409.64 crore (including accrued interest of Rs. 29.64 crore) for which carrying value, net of provision, is Rs 399.60 crore. Pursuant to the shareholders agreements entered into between Nippon Life Insurance Company (NLI), Reliance Capital Limited (RCL) and the Company for acquiring shares of Company from RCL and pursuant to framework agreement entered into between RCL, NLI, IndusInd Bank (escrow agent) and others, RCL and NLI have agreed that in the event of the ICDs remaining outstanding on conclusion of the transaction, the repayment of the ICDs out of the proceeds of sale of shares by RCL to NLI are secured by preference for payment. Accordingly, the Board of Directors of the Company have not considered any additional provisions in respect of such ICDs. The acquisition of the Company by NLI is subject to final applicable regulatory approvals.ttttt n4.tPursuant to resolution dated April 25, 2018, shareholders approved Reliance Nippon Life Asset Management Limited – Employee Stock Option Plan 2017 ('ESOP 2017') , to provide for grant of option to eligible employees of the Company and its subsidiaries. Under the scheme 11,190,706 equity shares have been granted to the eligible employees and each option (after it is vested) is exercisable for one equity share having face value of Rs 10 each for an exercise price of Rs 202.50. Vesting of the options shall take place over a maximum period of 4 years with a minimum vesting period of 1 year from the date of grant i.e. April 29, 2019. The exercise period would be maximum of 7 years from the date of grant of options.ttttt n5.tFigures for the quarter ended March 31, 2019 are derived by deducting the reported year to date figures for the period ended December 31 , 2018 from the audited figures for the year ended March 31, 2019.ttttt n6.tThe above results for the quarter ended June 30, 2019, which have been subjected to a Limited Review by the Statutory Auditors of the Company, were reviewed by the Audit Committee of Directors and subsequently approved by the Board of Directors at its meeting held on July 29, 2019, in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.ttttt n Fees & Commission Exoense 251800000.00 Other Expenses 628500000.00